Platform Technology Partners’s Anixa Biosciences ANIX Stock Holding History

Platform Technology Partners’s Portfolio ANIX Stock Details ANIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	$61K	Buy	+20,000	New	+$50.3K	0.03%	221

Other funds holding ANIX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

HPCM

Hunter Perkins Capital Management Lombard, Illinois $446M AUM 25.88% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $8.43B AUM 52.02% 1-Year Est. Return

Platform Technology Partners's ANIX Position: Q4 2020 in Review

Platform Technology Partners opened a new position in Anixa Biosciences (ANIX) in Q4 2020: 20,000 shares worth $61K. The stake represents 0.03% of the portfolio and ranks #221 among its holdings.

22 funds tracked by Wall St. Rank hold ANIX as of Q4 2020.

Platform Technology Partners held 20,000 shares of Anixa Biosciences worth $61K as of Q4 2020.
Anixa Biosciences was a new Platform Technology Partners position in Q4 2020.
Anixa Biosciences made up 0.03% of Platform Technology Partners's portfolio in Q4 2020, its #221 holding.
22 funds tracked by Wall St. Rank held Anixa Biosciences as of Q4 2020.

Based on Platform Technology Partners's 13F filing for Q4 2020, filed 9 Feb 2021.